Sign in
RVPHW Stock Price, Chart, Stats & News
Reviva Pharmaceuticals Holdings, Inc.
Save
Reviva Pharmaceuticals Holdings, Inc. (RVPHW) does not currently pay a dividend.
343,911
Market cap
–
Current P/E
–
Forward P/E
RVPHW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.09% |
ROA | -158.78% |
ROE | -20541.50% |
D/E | – |
Interest coverage ratio | -965.98x |
RVPHW valuation
P/E | – |
P/S | – |
P/B | 0.59x |
P/CF | -0.10x |
P/FCF | -0.09x |
P/OCF | -0.10x |
PEG | -0.00x |
EV multiple | -0.69x |
About
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia.
Similar securities
Based on sector and market capitalization
Report issue